Rani Therapeutics Holdings, Inc. (RANI)

NASDAQ: RANI · Real-Time Price · USD

0.8003

+0.0243 (3.13%)

At close: Sep 29, 2026, 4:00 PM EDT

0.8183

+0.0180 (2.25%)

After-hours: Sep 29, 2026, 7:30 PM EDT

RANI Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	4.88	1.63	1.03	-	-	2.72
Revenue Growth	306.42%	58.85%	-	-	-	488.10%
Gross Profit	4.88	1.63	1.03	-	-	2.72
Selling, General & Admin	19.53	19.74	23.95	26.48	26.84	27.83
Research & Development	18.31	20.21	26.68	39.62	36.61	26.48
Operating Expenses	37.84	39.94	50.63	66.1	63.45	54.32
Operating Income	-32.96	-38.31	-49.6	-66.1	-63.45	-51.6
Interest Expense	-1.17	-2.89	-5.03	-5.09	-1.07	-0.47
Interest & Investment Income	1.28	0.83	1.76	3.3	1.25	0.09
Other Non Operating Income (Expenses)	-	-	-	-	-	-0.37
EBT Excluding Unusual Items	-32.85	-40.37	-52.87	-67.88	-63.27	-52.35
Asset Writedown	-	-	-3.71	-	-	-
Other Unusual Items	-0.58	-0.58	-	-	-	-0.7
Pretax Income	-33.42	-40.95	-56.58	-67.88	-63.27	-53.05
Income Tax Expense	-	-	-	-	0.07	0.04
Earnings From Continuing Operations	-33.42	-40.95	-56.58	-67.88	-63.34	-53.09
Minority Interest in Earnings	3.28	11.28	26.57	33.91	32.76	44.76
Net Income	-30.14	-29.67	-30.02	-33.97	-30.59	-8.33
Net Income to Common	-30.14	-29.67	-30.02	-33.97	-30.59	-8.33
Net Income Growth	-	-	-	-	-	-
Shares Outstanding (Basic)	139	66	28	26	24	20
Shares Outstanding (Diluted)	139	66	28	26	24	20
Shares Change	321.63%	132.26%	11.65%	7.09%	21.93%	-58.34%
EPS (Basic)	-0.22	-0.45	-1.05	-1.33	-1.28	-0.43
EPS (Diluted)	-0.22	-0.45	-1.05	-1.33	-1.28	-0.43
EPS Growth	-	-	-	-	-	-

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Free Cash Flow	-20.34	-18.8	-35.76	-52.47	-48.13	-32.75
Free Cash Flow Per Share	-0.15	-0.28	-1.26	-2.06	-2.02	-1.68
Gross Margin	100.00%	100.00%	100.00%	-	-	100.00%
Operating Margin	-675.80%	-2345.99%	-4824.90%	-	-	-1899.12%
Profit Margin	-618.02%	-1817.09%	-2920.04%	-	-	-306.63%
Free Cash Flow Margin	-417.04%	-1151.38%	-3478.99%	-	-	-1205.41%
EBITDA	-32.24	-37.41	-48.57	-65.28	-62.9	-51.1
D&A For EBITDA	0.72	0.9	1.03	0.82	0.55	0.5
EBIT	-32.96	-38.31	-49.6	-66.1	-63.45	-51.6

SEC Filings: 10-K · 10-Q